Oncotelic Therapeutics, Inc. Payments to Acquire Short-term Investments
Oncotelic Therapeutics, Inc. (OTLC) reported Payments to Acquire Short-term Investments of $21.01 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-04-17.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2018-04-17
- Oncotelic Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2016-12-31 was $2.10M.
- Oncotelic Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2016-09-30 was $3.31M.
- Oncotelic Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2016-06-30 was $2.99M.
- Oncotelic Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2016-03-31 was $12.61M.
- Oncotelic Therapeutics, Inc. payments to acquire short-term investments for fiscal 2016 was $21.01M.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2016-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | $5.41M derived: sum of 2 quarters · filed 2018-04-17 | $8.40M derived: sum of 3 quarters · filed 2018-04-17 | $21.01M 10-K · filed 2018-04-17 |
| 2016-09-30 | $3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $6.30M derived: sum of 2 quarters · filed 2017-11-14 | $18.91M 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $15.60M 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | $12.61M 10-Q · filed 2017-05-08 |